Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study
Abstract Limited information is available on the efficacy of front‐line bendamustine and rituximab (BR) in chronic lymphocytic leukemia (CLL) with reduced renal function or coexisting conditions. We therefore analyzed a cohort of real‐world patients and performed a matched adjusted indirect comparis...
Similar Items
-
Unfit for the Future by Laura Crompton
by: Laura Crompton
Published: (2014-05-01) -
MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT
by: Deepak Kumar Shukla, et al.
Published: (2021-01-01) -
Medical unfitness for work at sea: causes and incidence rate over a 12-year period in France
by: Brice Loddé, et al.
Published: (2021-01-01) -
Deep Unfitted Nitsche Method for Elliptic Interface Problems
by: Guo, H., et al.
Published: (2022) -
Urothelial carcinoma management in elderly or unfit patients
by: Joaquim Bellmunt, et al.
Published: (2016-03-01)